The ChEMBL-og - Open Data For Drug Discovery

The news, progress, whereabouts, and ephemera from the Computational Chemical Biology group at the EMBL-EBI.

ChEMBL Resources

ChEMBL database ChEMBL-NTD GPCR SARfari Kinase SARfari DrugEBIlity ADMET SARfari

ESFRIs

ELIXIR
EATRIS
BBMRI
ECRIN
INFRAFRONTIER
INSTRUCT
EU-OPENSCREEN
Email ThisBlogThis!Share to TwitterShare to Facebook

Home
Subscribe to: Posts (Atom)

Google+

About ChEMBL


The ChEMBL-og covers the activities of the Computational Chemical Biology Group at the EMBL-EBI in Hinxton. Our interests cover Drug Discovery, Computational Chemical Biology, Chemogenomics, Chemoinformatics, Bioinformatics, Structural Biology, Pharmacogenomics, Open Data, Knowledge Management, Semantic Web, and Data Integration and include...
  • ChEMBLdb - a drug discovery SAR and bioactivity database.
  • SARfari - a sequence, binding site, structure, SAR integration platform.
  • DrugEBIlity - Drug target annotation & prioritisation.
  • ChEMBL-NTD Data repository for neglected tropical diseases.
  • Open Source Intelligence (OSINT), Public-Private partnerships & Precompetitive activities.
More details of our interests can be found here, and details of some of our publications here.

budapest

Chembl Out Of The Office

Subscribe To The ChEMBL-og

Posts
Atom
Posts
All Comments
Atom
All Comments

ChEMBL-og Popular Posts

  • How far behind the patent literature is the primary literature?
    I can't believe that people haven't looked at this before, and I should have looked on 'The Interwebs', so I'm not claiming this is worl...
  • New Drug Approvals 2012 - Pt. XI - Taliglucerase alfa (ElelysoTM)
    ATC code :   A16AB11 Wikipedia : Taliglucerase alfa   On May 1, the FDA approved taliglucerase alfa for the treatment of Type I Gau...
  • New Drug Approvals 2012 - Pt. X - Avanafil (StendraTM)
    ATC code :   G04BE (partial) Wikipedia : Avanafil On April 27th, the FDA approved Avanafil (tradename: Stendra ; Research Code: TA...
  • Why Drug Repurposing for Small Molecule Drugs is Probably Best Done in Academia
    There was a lovely paper in Nature Medicine recently by James McKerrow and colleagues from UCSF on the discovery that auranofin is a g...
  • Are there around 1019 Lipinski-like small molecules?
    I'm a big fan of the work of Jean-Louis Reymond at the University of Berne , and am starting to imagine a time when the enormity of chemi...

ChEMBL Databases and Microsites

  • UniChem
  • ChEMBLdb
  • DrugEBIlity
  • ChEMBL-NTD
  • ChEMBL FAQs
  • GPCR SARfari
  • Open PHACTS
  • Kinase SARfari
  • ChEMBL Group
  • eTox IMI Project
  • EU-OPENSCREEN
  • jpo's work library
  • Pipeline Pilot Server
  • EMBL-EBI Systems News
  • ChEMBL Data Entry Portal

Research Notebooks

  • Rita's Notebook
  • Felix's Notebook
  • Ben's Notebook
  • Patricia's Notebook

Various ChEMBL Pages

  • Home
  • GPCR Structures
  • Large Scientific Meetings And Organisations
  • Research Code Stems

Some Of The Other stuff we have done

  • Joy - Protein structure residue markup
  • Homstrad - aligned 3-D protein structures

ChEMBL-og Labels

  • 2008 New Drugs (3)
  • 2009 New Drugs (30)
  • 2010 New Drugs (20)
  • 2011 New Drugs (33)
  • 2012 New Drugs (11)
  • ADMET SARfari (1)
  • API (5)
  • Bioclipse (1)
  • Black Box Warning Drugs (9)
  • Books and Papers (42)
  • Cancer (2)
  • Cell-Based Drugs (2)
  • Chembl Releases (12)
  • ChUG (5)
  • Conferences (66)
  • Conflict of Interest; Disclosure; Privacy (3)
  • Crowdsourcing (1)
  • Databases (107)
  • Drug Attrition (2)
  • Drug Discovery Blogs (1)
  • Drug Repurposing (4)
  • DrugEBIlity (8)
  • EMBL and EMBL-EBI (5)
  • Enzyme drugs (6)
  • EU-OPENSCREEN (4)
  • FAQ (4)
  • First-in-class Drugs (2)
  • Funding (1)
  • GPCRs (21)
  • Hinxton Campus Drug Discovery Talks. (1)
  • Hit-the-Sack (13)
  • Humour (maybe) (9)
  • Imaging Agents (1)
  • IMI eTox Project (1)
  • INNS and USANS (30)
  • Interfaces (8)
  • Internships (1)
  • Kinase inhibitor (16)
  • Kool-And-The-Gang (7)
  • Licensing (3)
  • mAb Drugs (11)
  • MoSS (1)
  • Movember 2011 (7)
  • Natural Product Drugs (12)
  • Natural Product of the Day (3)
  • Neglected Tropical Diseases (12)
  • Ontologies (3)
  • Open PHACTS (1)
  • Oral Drugs (4)
  • Outreach (54)
  • Parenteral Drugs (2)
  • Patents (1)
  • Peptide Drugs (6)
  • Physical Compounds (1)
  • PPIs (3)
  • Prodrugs (3)
  • Programming (8)
  • Protein-Protein Interactions (1)
  • QSAR (1)
  • Radiopharmaceuticals (1)
  • Robot Chemist (3)
  • SARfari (14)
  • Science Blogging (1)
  • Semantic Web (1)
  • Small Molecule Drugs (25)
  • Software (12)
  • Some Of The Interesting Things You'll See On A Long Distance Flight (47)
  • Staff and Recruitment (53)
  • Systems Biology (1)
  • Topical Drugs (1)
  • UK Academic Drug Discovery (1)
  • UK Chemical Biology (1)
  • UniChem (1)
  • web (2)
  • Web Services (5)
  • Webinar (15)

ChEMBL-og Archive

  • ►  2012 (93)
    • ►  May (14)
      • Costs of Assays
      • Love Drug Information? 17th July 2012
      • Radio 4 broadcast on Drug Discovery - Tuesday 22nd...
      • GPCR Structures: delta opioid and nociceptin recep...
      • Why Drug Repurposing for Small Molecule Drugs is P...
      • ChEMBL Webinar 16th May 'Schema & SQL Querying' - ...
      • USAN Watch - May 2012
      • New Drug Approvals 2012 - Pt. XI - Taliglucerase a...
      • Are there around 1019 Lipinski-like small molecule...
      • PPI Library - Part 3
      • Deadline Approaching for Computational Drug Discov...
      • How far behind the patent literature is the primar...
      • New Drug Approvals 2012 - Pt. X - Avanafil (Stendr...
      • ChEMBL Webinar on 30th May in Japanese only
    • ►  April (12)
      • Last chance to sign up for the webinar on Web Serv...
      • Bio-IT World, Boston
      • Some Summer Reading - The Ultimate Inferior Beings...
      • Canadian Bioinformatics Workshop
      • New Drug Approvals 2012 - Pt. IX - Florbetapir F 1...
      • ChEMBL Workflows for medicinal chemists workshop
      • Interface & Searching Webinar 18th April
      • USAN Watch - April 2012
      • Joint EMBL-EBI and WT Resources for Computational ...
      • Some New GPCR Structures (Coming)
      • We all know just how useless HTS is, don't we?
      • New Drug Approvals 2012 - Pt. VIII - Peginesatide ...
    • ►  March (24)
      • My Morel Guardian
      • Target Discovery Institute, Oxford, UK.
      • Structure-Based DrugEBIlity Webinar 4th April
      • Blogging from the ACS
      • Update on EMBO Chemical Biology 2012
      • Crowdsourcing for scientific tasks
      • GPCR Structures: mu and kappa opioid structures
      • Conference: Cutting Edge Approaches to Drug Design...
      • Some good news for startups!
      • ChEMBL Schema & SQL Querying Webinar
      • How much does google analytics under-report things...
      • ChEMBL in rdf form using TopBraid.
      • Tender: Consultancy services for OPS licensing and...
      • The 22nd Jyväskylä Summer School
      • USAN Watch - March 2012
      • PPI Library - Part 2
      • New Drug Approvals 2012 - Pt. VII - Lucinactant (S...
      • A reminder of the course being held on campus h...
      • ChEMBL Webinars
      • Meeting: ECBS2012 - 3rd European Chemical Biology ...
      • Webinar Reminder
      • PPI Library - part 1
      • A Dating Site For Chemists and Biologists
      • Pfam domain searching of targets in ChEMBL
    • ►  February (28)
    • ►  January (15)
  • ►  2011 (200)
    • ►  December (17)
    • ►  November (21)
    • ►  October (18)
    • ►  September (17)
    • ►  August (18)
    • ►  July (7)
    • ►  June (16)
    • ►  May (25)
    • ►  April (10)
    • ►  March (21)
    • ►  February (13)
    • ►  January (17)
  • ▼  2010 (148)
    • ►  December (12)
    • ►  November (19)
    • ▼  October (17)
      • New GPCR structures - CXCR4 now available from PDB...
      • Contractor Positions Within ChEMBL
      • Staff Post in ChEMBL - EU-OPENSCREEN Database deve...
      • PhD studentship at the ICR: chemogenomics and net...
      • Internships within ChEMBL
      • ChemSpider links now available in ChEMBLdb
      • INNS for kinase inhibitors - October 2010
      • USAN Watch - October 2010
      • ChEMBL_07 Downloads Available
      • 2010 New Drug Approvals - Pt. XII - Pegloticase (K...
      • Science Is Vital!
      • Surrounded by Old Fossils!
      • DrugEBIlity - Structure-based component
      • ChEMBL licensing
      • 2010 New Drug Approvals - Pt. XIII - Fingolimod (G...
      • ChEMBL_07 is now live
      • ChUG - The Chembl User Group
    • ►  September (15)
    • ►  August (12)
    • ►  July (11)
    • ►  June (10)
    • ►  May (12)
    • ►  April (10)
    • ►  March (9)
    • ►  February (8)
    • ►  January (13)
  • ►  2009 (165)
    • ►  December (7)
    • ►  November (18)
    • ►  October (18)
    • ►  September (12)
    • ►  August (14)
    • ►  July (14)
    • ►  June (12)
    • ►  May (12)
    • ►  April (10)
    • ►  March (16)
    • ►  February (18)
    • ►  January (14)
  • ►  2008 (20)
    • ►  December (8)
    • ►  November (7)
    • ►  October (4)
    • ►  September (1)

EMBL-EBI Industry Programme

  • General events calendar
  • Industry Workshops
  • Industry Quarterly Strategy Meetings
  • Industry Web Page
  • Industry Brochure

Funding Agencies

  • Association of Medical Research Charities
  • BBSRC
  • Bill & Melinda Gates Foundation
  • Council of Foundations
  • EPSRC
  • Framework 7
  • Innovative Medicines Initiative
  • MRC
  • National Institute of Health
  • Wellcome Trust

Professional Societies and Organizations

  • AAAS
  • ACS
  • Cambridge Infectious Disease
  • CASE
  • Fortran Standards
  • International Society for Biocuration
  • ISSX
  • IUPHAR
  • La Société de Chimie Thérapeutique
  • MGMS
  • Royal Society of Chemistry (RSC)
  • Society for Medicines Research (SMR)
  • Society of Chemical Industry (SCI)
  • The Chemoinformatics and QSAR Society
  • UK QSAR and Chemoinformatics Group

Literature Links

  • OSRA
  • PubMed
  • BioTorrents
  • EMBL Library
  • Sanger Library
  • PubMed Central
  • Nature Magazine
  • Science Magazine
  • The Cochrane Collaboration
  • ISI Web of Knowledge (license needed)

EMBL-EBI Recruitment

  • EMBL-EBI PhD Studentships
  • EMBL-EBI Jobs

Labs and Projects

  • CanSAR
  • iBabel
  • CACTUS @ NCI blog
  • AffinDB
  • Binding MOAD
  • BindingDB
  • BRENDA
  • CACTUS
  • Chem-GPS
  • ChemBank
  • ChemBioBank
  • Chemicals of Biological Interest (ChEBI)
  • Chemistry Development Kit (CDK)
  • ChemSpider
  • CTSA Genome Center
  • Drug Discovery at Dundee
  • Drug Free World
  • DrugBank
  • DrugLead
  • EMBL Heidelberg
  • EMBL-EBI
  • European Screening Port
  • GGobi
  • History of Drugs
  • HOPL
  • InChI Trust
  • Information Aesthetics
  • Institute of Cancer Research
  • International Society for Biocuration
  • IUPHAR Database
  • LipidBank
  • MINT
  • MMsINC
  • NCI Drug Dictionary
  • NIMH Psychoactive Drug Screening Program
  • Office of Health Economics (OHE)
  • Orphanet
  • PDBBind
  • Pharmaceutical Business Review
  • Pistoia Alliance
  • PubChem
  • Reactome
  • Sali lab
  • Seattle Biomedical Research Institute
  • Structural Genomics Consortium (SGC)
  • Swiss Institute Bioinformatics (SIB)
  • Target Detective
  • Taverna
  • The Urban Pantheist
  • UK PubMed Central
  • UK Systems Biology Centres
  • WHO Drug Information

Clinical Trials Portals

  • Clinicaltrials.gov
  • IFPMA

Neglected Tropical Disease Links

  • DNDI
  • WWARN
  • PlasmoDB
  • TDR Targets
  • Medicines for Malaria Venture
  • British Society for Parasitology
  • World Federation of Parasitologists
  • Liverpool School of Tropical Medicine
  • London School Hygiene and Tropical Medicine
  • American Society of Tropical Medicine and Hygiene
Blog content licensed as CC0 EMBL-EBI -------. Simple template. Powered by Blogger.